Jeff Blank - Ataxia Stem Cell Patient
Jeff Blank returned to China for his second round of stem cell transplants toward the treatment of his Spinal Cerebellar Ataxia 6 (SCA6). This time Jeff traveled to Hangzhou Xiaoshan Hospital and spent a month there receiving several injections and intensive physical therapy. Ataxia is often a hereditary condition. Jeff discusses the choices he has made to leave the US to seek out medical treatments unavailable within its borders.
Improvement statistics
Based on follow-up reports from 143 patients across 415 forms, here is the percentage who self-reported any improvement after treatment.
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
